拟除虫菊酯原药
Search documents
扬农化工的前世今生:2025年Q3营收91.56亿行业第四,净利润10.56亿位居榜首
Xin Lang Cai Jing· 2025-10-31 07:04
Core Viewpoint - Yangnong Chemical is a leading player in the domestic agrochemical industry and a core supplier of pyrethroid raw materials globally, with a focus on research, production, and sales of pesticide products [1][6]. Group 1: Business Performance - As of Q3 2025, Yangnong Chemical reported revenue of 9.156 billion yuan, ranking 4th among 32 companies in the industry, with the top competitor, ADAMA, at 21.678 billion yuan [2]. - The net profit for the same period was 1.056 billion yuan, placing Yangnong Chemical first in the industry, while the second competitor, Runfeng, reported 999 million yuan [2]. Group 2: Financial Ratios - The company's debt-to-asset ratio stood at 39.43% in Q3 2025, slightly up from 39.32% year-on-year, which is lower than the industry average of 46.06%, indicating strong solvency [3]. - The gross profit margin was 22.35%, down from 24.02% year-on-year but still above the industry average of 21.70% [3]. Group 3: Management and Shareholder Information - The chairman, Su Fu, and the general manager, Wu Xiaojun, have significant roles in the company, with Wu's salary for 2024 set at 2.2 million yuan, a substantial increase from 0 in 2023 [4]. - As of September 30, 2025, the number of A-share shareholders decreased by 6.49% to 16,900, while the average number of shares held per shareholder increased by 7.24% to 23,900 [5]. Group 4: Future Outlook and Innovations - The company is advancing its projects, with the Huludao project achieving full design capacity in its first phase and ongoing progress in the second phase [6]. - Yangnong Chemical is accelerating the commercialization of new drugs and has received approval for a national postdoctoral research workstation, indicating a commitment to innovation [6]. - The sales volume of raw materials and formulations for Q3 2025 was 30,000 tons and 5,000 tons, respectively, with a year-on-year increase of 13.5% for raw materials and a decrease of 17.6% for formulations [6].